Human Resources Coordinator

SCILEX HOLDING COMPANY (Nasdaq: SCLX, “Scilex”), is dedicated to the development and commercialization of non-opioid pain management products. We are uncompromising in our focus to become the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products to maximize quality of life.The company’s lead product ZTlido (lidocaine topical system) 1.8%, is a marketed prescription lidocaine topical product approved by the U.S. Food and Drug Administration for the relief of pain associated with Post-Herpetic Neuralgia (PHN), which is a form of post-shingles nerve pain. ZTlido possesses novel delivery and adhesion technology designed to address many of the limitations of current prescription lidocaine patches by providing significantly improved adhesion and continuous pain relief throughout the 12-hour administration period.We have acquired two FDA approved non-opioid pain products, GLOPERBA and ELYXYB TM, for the treatment of gout in adults and oral solution for the acute treatment of migraine, with or without aura, in adults. We launched ELYXYB TM in the U.S. in April 2023 and launched GLOPERBA in 2024.Our three product candidates are (i) SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (“SEMDEXA TM”), a Phase 3, novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica and has received Fast Track Status from the FDA; (ii) SP-103 (lidocaine topical system) 5.4%, (“SP-103”), a Phase 2, next-generation, triple-strength formulation of ZTlido, for the treatment of low back pain (“LBP”) and has received Fast Track Status from the FDA; and (iii) SP-104 (4.5 mg, low-dose naltrexone hydrochloride delayed-release capsules) (“SP-104”), a novel low-dose delayed-release naltrexone hydrochloride being developed for the treatment of fibromyalgia. If these product candidates are approved by the FDA, we believe each of them could become the treatment option for their respective indications in the United States.SCILEX is committed to harnessing the power of revolutionary delivery technologies designed to safely and effectively provide therapies to those who need them the most. Scilex Pharmaceuticals and Semnur Pharmaceuticals are wholly-owned subsidiaries of Scilex Holding Company.Role and ResponsibilitiesProvide administrative support to HR Executive and HR Managers.Assist in preparing various confidential human resources documents and final signatures.Assist in onboarding/offboarding processes.Assist in recruitment processes such as coordinate communication with candidates and schedule interviews.Assist with maintenance of employee records on HRIS platform.Assist in candidate screening.Manage staff supplies in breakrooms and supply rooms.Assist in scheduling both internal and external HR meetings.Manage the department’s updates on the company’s intranet.Collaborate with the entire human resource team.Manage and submit sensitive files to SharePoint and other alternative platforms.Manage department calendars, schedules, and travel arrangements, prioritize meetings.Coordinate HR projects (meetings, training, surveys, etc.) and take minutes.Assist with internal and external company/department events working with other department administrative assistants.Handle all incoming department calls, visitors, mail, department email and screening/directing as necessary.Manage HR compliance postings and events.Schedule employee wellness programs.Assist with various administrative tasks assigned.Qualifications and Education Requirements3-5 years proven experience as an HR assistant, staff assistant or relevant human resources/administrative position.Preferred college or relevant experience in HR.Hands on experience with an HRIS or HRMS systems (UKG is a plus).Basic knowledge of labor laws.Excellent organizational skills.Strong verbal and written communication skills.Handle confidential materials and matters with discretion.Technical skills in Microsoft Suite (Outlook), Adobe, HRIS (UKG), Concur or equivalent.

#J-18808-Ljbffr